Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 2
1992 2
1993 6
1994 5
1995 8
1996 3
1997 4
1998 1
1999 6
2000 3
2002 7
2003 3
2004 3
2005 6
2006 5
2007 2
2008 1
2011 1
2012 1
2013 5
2014 1
2015 12
2016 17
2017 9
2018 14
2019 13
2020 5
2021 20
2022 13
2023 9
2024 15
2025 12
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel-group, multicentre, open-label trial (COMING study).
Kimura T, Katakura Y, Shimoda M, Kawasaki F, Yamabe M, Tatsumi F, Matsuki M, Iwamoto Y, Anno T, Fushimi Y, Kamei S, Kimura Y, Nakanishi S, Mune T, Kaku K, Kaneto H; COMING study Group. Kimura T, et al. Among authors: mune t. Diabetes Obes Metab. 2023 Dec;25(12):3632-3647. doi: 10.1111/dom.15258. Epub 2023 Aug 30. Diabetes Obes Metab. 2023. PMID: 37646192 Clinical Trial.
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor agonist, exhibits favourable effects on pancreatic β-cells and hepatic steatosis in obese type 2 diabetic db/db mice.
Iwamoto Y, Kimura T, Dan K, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Shimoda M, Yamasaki Y, Nogami Y, Shirakiya Y, Nakanishi S, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: mune t. Diabetes Obes Metab. 2024 Dec;26(12):5982-5994. doi: 10.1111/dom.15972. Epub 2024 Sep 30. Diabetes Obes Metab. 2024. PMID: 39344853
Comparison of protective effects of teneligliptin and luseogliflozin on pancreatic β-cell function: randomized, parallel-group, multicenter, open-label study (SECRETE-I study).
Shimoda M, Katakura Y, Mashiko A, Iwamoto M, Nakanishi S, Anno T, Kawasaki F, Obata A, Fushimi Y, Sanada J, Kohara K, Isobe H, Iwamoto Y, Hirukawa H, Tatsumi F, Kimura Y, Kimura T, Mune T, Kaku K, Kaneto H. Shimoda M, et al. Among authors: mune t. Front Endocrinol (Lausanne). 2024 Oct 21;15:1412553. doi: 10.3389/fendo.2024.1412553. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39497800 Free PMC article. Clinical Trial.
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry).
Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T; J-BRAND Registry Group. Ueki K, et al. BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001787. doi: 10.1136/bmjdrc-2020-001787. BMJ Open Diabetes Res Care. 2021. PMID: 33441417 Free PMC article.
Blocking mineralocorticoid signaling with esaxerenone reduces atherosclerosis in hyperglycemic ApoE KO mice without affecting blood pressure and glycolipid metabolism.
Iwamoto H, Sanada J, Kimura T, Shimoda M, Iwamoto Y, Dan K, Fushimi Y, Katakura Y, Nogami Y, Shirakiya Y, Yamasaki Y, Nakanishi S, Mune T, Kaku K, Kaneto H. Iwamoto H, et al. Among authors: mune t. Sci Rep. 2025 Mar 29;15(1):10887. doi: 10.1038/s41598-025-95324-z. Sci Rep. 2025. PMID: 40157997 Free PMC article.
Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching.
Iwamoto H, Kimura T, Fushimi Y, Iwamoto M, Tatsumi F, Sanada J, Iwamoto Y, Katakura Y, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H. Iwamoto H, et al. Among authors: mune t. Diabetes Obes Metab. 2024 Oct;26(10):4366-4374. doi: 10.1111/dom.15784. Epub 2024 Jul 22. Diabetes Obes Metab. 2024. PMID: 39039725
Persistent Hypoglycemia Induced by Long-acting Insulin Degludec.
Katakura Y, Tatsumi F, Kusano T, Shimoda M, Kohara K, Kimura T, Obata A, Nakanishi S, Mune T, Kaku K, Kaneto H. Katakura Y, et al. Among authors: mune t. Intern Med. 2022 Mar 15;61(6):861-864. doi: 10.2169/internalmedicine.7915-21. Epub 2021 Sep 4. Intern Med. 2022. PMID: 34483209 Free PMC article.
Temporal lobe epilepsy associated with GAD autoimmunity.
Obata A, Kutoku Y, Sunada Y, Okauchi S, Kimura T, Hirukawa H, Tanabe A, Kinoshita T, Kohara K, Tatsumi F, Shimoda M, Kamei S, Nakanishi S, Mune T, Kaku K, Kaneto H. Obata A, et al. Among authors: mune t. Acta Diabetol. 2017 Mar;54(3):321-323. doi: 10.1007/s00592-016-0910-9. Epub 2016 Sep 8. Acta Diabetol. 2017. PMID: 27638303 Free PMC article. No abstract available.
197 results